Skip to main content

Table 2 Logistic regression analyses for low FMD in diabetic patients

From: Serum apolipoprotein A-IV levels are associated with flow-mediated dilation in patients with type 2 diabetes mellitus

 

Variables

OR (95% CI)

P value

Model 1

Male

0.819 (0.226 ~ 2.966)

0.761

Nagelkerke R2 = 0.304

Age

1.076 (0.993 ~ 1.167)

0.073

Hosmer–Lemeshow test:

BMI

0.963 (0.800 ~ 1.161)

0.695

P = 0.872

Hypertension

0.777 (0.225 ~ 2.681)

0.690

Smoke

0.561 (0.180 ~ 1.748)

0.319

eGFR

0.999 (0.959 ~ 1.040)

0.956

Log hsCRP

1.469 (0.993 ~ 2.171)

0.049

HbA1c

0.978 (0.646 ~ 1.480)

0.915

HOMA-IR

1.125 (0.914 ~ 1.385)

0.265

DM duration

1.079 (0.992 ~ 1.174)

0.077

Total-to-HDL cholesterol ratio

1.278 (0.728 ~ 2.274)

0.386

Model 2

Male

0.705 (0.151 ~ 3.283)

0.656

Nagelkerke R2 = 0.482

Age

1.052 (0.961 ~ 1.152)

0.271

Hosmer–Lemeshow test:

BMI

1.018 (0.821 ~ 1.275)

0.877

P = 0.930

Hypertension

1.179 (0.304 ~ 4.579)

0.812

Smoke

0.911 (0.244 ~ 3.399)

0.890

eGFR

0.995 (0.951 ~ 1.040)

0.812

Log hsCRP

1.621 (1.018 ~ 2.580)

0.042

HbA1c

0.824 (0.502 ~ 1.351)

0.442

HOMA-IR

1.112 (0.907 ~ 1.364)

0.305

DM duration

1.091 (0.987 ~ 1.205)

0.088

Total-to-HDL cholesterol ratio

1.346 (0.680 ~ 2.663)

0.394

ApoA-IV

0.906 (0.855 ~ 0.959)

0.001

  1. Model 1, adjusted for conventional cardiovascular factors
  2. Model 2, adjusted for the factors included in Model 1 with the addition of apoA-IV
  3. BMI Body mass index, eGFR estimated glomerular filtration rate, hsCRP high sensitive C reactive protein, HbA1c glycosylated hemoglobin A1c, HOMA-IR Homeostatic model assessment for insulin resistance, HDL High-density lipoprotein, FMD Flow-mediated dilation